GABA Therapeutics, Inc
www.gabarx.comGABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive. By naturally increasing neurosteroids, the drug could also benefit a broad range of other neuropsychiatric and neurological disorders.
Read more
GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive. By naturally increasing neurosteroids, the drug could also benefit a broad range of other neuropsychiatric and neurological disorders.
Read more
Country
State
California
City (Headquarters)
Newport Beach
Industry
Employees
11-50
Founded
2018
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer and Chief Marketing Officer
Email ****** @****.comPhone (***) ****-****Co - Founder and Chief Financial Officer / Chief Operations Officer
Email ****** @****.comPhone (***) ****-****Chairman of the Board
Email ****** @****.comPhone (***) ****-****
Technologies
(19)
Reach decision makers at GABA Therapeutics, Inc
Free credits every month!
GABA Therapeutics, Inc FAQ
Newport Beach, United States
Pharmaceutical Manufacturing
